When Will Moderna's COVID-19 Vaccine Be Approved for Kids?
Moderna submitted a request in June for emergency use authorization of its two-shot COVID-19 vaccine for children aged 12–17. The FDA hasn’t given its approval yet.
Healthcare
The latest news in the healthcare sector including biotech and telehealth.
Who Owns the Malaria Vaccine? First Vaccine Against Parasitic Disease Receives WHO Approval
Who owns the malaria vaccine? The first vaccine against parasitic disease receives WHO approval
Only Certain People Are Eligible for Pfizer's COVID-19 Booster Shot
Those who are eligible for the Pfizer vaccine booster shot fall under specific groups deemed to be at higher risk of reinfection or server disease.
Why 2021 Could Be a Very Healthy Year for Merck Stock
Merck stock rose 8 percent on Oct. 1, and was higher in premarket trading on Oct. 4. What’s the forecast for MRK stock?
Study Shows Merck Antiviral Drug Is Effective in Treating COVID-19
A recent study found that Merck's antiviral drug is effective in treating COVID-19. The jury is still out on whether the drug is as effective as the vaccine.
When Will the Pfizer Vaccine Be Approved for Children Under 12?
Parents and schools are eagerly awaiting COVID-19 vaccines for younger children as the Delta variant spreads. When will Pfizer's vaccine be approved for children under 12?
When Will the FDA Fully Approve Moderna's COVID-19 Vaccine?
Investors want to know when the FDA will fully approve Moderna’s COVID-19 vaccine. FDA approval could fuel sales. Here's what investors can expect.
Why TransCode (RNAZ) Stock Is Going Up, Looks Like a Good Buy
TransCode Therapeutics stock was trading sharply higher on Sept. 22. Why is RNAX stock going up and what’s the forecast for the stock?
Can SDC Stock Make You ‘Smile’ Amid Evergrande Slump?
Currently, SmileDirectClub is among the popular stocks on Reddit group WallStreetBets. Is SDC a good stock to buy now?
When Will COVID-19 Vaccine Boosters Be Available?
With conflicting advice about COVID-19 vaccine booster shots, when will they be available for Americans? What are the current recommendations?
Why Is SmileDirectClub (SDC) Stock Rising, and What’s Its Forecast?
The short volumes of SDC stock look high enough to trigger a squeeze. What’s SDC’s stock forecast, and how high can Reddit investors take it?
How to Enroll a Child in a COVID-19 Vaccine Trial
Clinical trials for COVID-19 vaccine safety and effectiveness in children under 12 are ongoing. Demand for trial participation is high, so parents might need to be patient.
Pfizer Paid the Largest Criminal Fine in U.S. History—Lawsuit Details
GlaxoSmithKline might have settled the largest healthcare lawsuit in U.S. history, by Pfizer still holds the record for paying the largest criminal fine.
Will There Be a Johnson & Johnson (JNJ) Booster Shot for COVID-19?
Will there be a booster shot for those who got the Johnson & Johnson COVID-19 vaccine? Health agencies will allow boosters for Pfizer and Moderna soon.
Cardiol Therapeutics (CRDL) Stock Looks Like an Attractive Investment
Cardiol Therapeutics, a clinical stage biotech company, has seen its stock hit a 52-week high recently. What's CRDL's stock forecast?
HGEN Stock Should Rebound, Good Time for Investors to Buy the Dip
Humanigen (HGEN) stock was trading sharply lower in the premarket on Sept. 9. Why is HGEN stock falling and should you buy the dip now?
Kadmon's (KDMN) Stock Price Forecast Ahead of Its Sanofi Acquisition
On Sept. 8, Sanofi agreed to acquire Kadmon for about $1.9 billion. What’s KDMN’s stock price forecast and is it a good buy ahead of the acquisition?
Moderna Has Not Got FDA Approval Yet, but Might Get It Soon
Pfizer-BioNTech vaccine became the first vaccine to be fully approved for COVID-19 by the FDA. Moderna’s vaccine is still awaiting FDA approval, but why?
Sonnet BioTherapeutics (SONN) Stock Is a Good Bet for High-Risk Investors
SONN’s stock forecast is in focus after the company picked a new pipeline candidate. Is SONN stock a good long-term investment?
Why Is SAVA Stock Being Shorted? Controversy Around Alzheimer's Drug
Why is SAVA stock being shorted? There has been controversy around its Alzheimer's drug research. Here's what investors can expect.
Why Is Zomedica Rising, and Is It Still a Buy?
Zomedica (ZOM) stock rose almost 14 percent on Aug. 25. Why is ZOM stock rising, and what’s the forecast for the stock in 2021?
Avalon GloboCare (AVCO) Stock Is a Good Bet for High-Risk Investors
Avalon GloboCare stock has fallen from its peak. What's the forecast for AVCO in 2021? Will it go up, and is it a good penny stock to buy now?
BioNTech Stock Forecast: BNTX Could Rise After FDA Approval
BioNTech (BNTX) stock was trading sharply higher after getting full FDA approval for its COVID-19 vaccine. What's the forecast for the stock and how high can it go?
CytoDyn Stock Forecast: Should You Buy CYDY Amid the Proxy Fight?
There's a proxy war going on between CytoDyn and activist investors. The forecast for CYDY stock looks positive amid the leronlimab trials.
Moderna Stock Falls, Could Go Back Up Amid Pumping From WallStreetbets
Moderna stock has come off its highs. Why is the stock falling and will it go back up on pumping from Reddit forum WallStreetBets?
Is Clover Health (CLOV) Stock Pricing in Most of the Negatives?
Clover Health stock has had a volatile run as a publicly traded company. However, after declining by nearly 39 percent in July, the stock has recouped some of the losses lately.
AXSM Stock Should Rebound, Good Time for Investors to Buy the Dip
Axsome Therapeutics (AXSM) stock has hit a 52-week low. What's the forecast for AXSM stock and will it go back up? Here's what investors can expect.
SENS Stock Forecast in August, Rise or Fall Depends on Q2 Earnings
Senseonics (SENS) is set to release its earnings in August. What's the forecast for the stock? Will the stock rise or fall? Here's what investors can expect.
BeyondSpring (BYSI) Stock Is a Good Investment, Wait for Better Price
BYSI stock rose 176 percent on Aug. 4. What’s BYSI’s stock forecast and how high can it reasonably go? Will it reach $100?
Why Infinity Pharma (INFI) Offers Solid Upside Potential From Here
Infinity Pharmaceuticals (INFI) stock has experienced wild swings lately. The company disclosed the clinical trial results for its leading candidate eganelisib.
Glenmark Life Sciences—IPO How to Check Allotment Application Status
Glenmark Life Sciences has its IPO this week and is highly oversubscribed. Here's how to check your allotment application status.
Vicarious Surgical Could Go Public in Q3 Through SPAC Merger
Robotics company Vicarious Surgical is expected to go public sometime in the third quarter of 2021 through a merger with a SPAC.
Pros and Cons to Critical Illness Insurance—Coverage, Explained
Should you get critical illness insurance? Find out what this type of coverage is—and isn’t—and what experts say about its utility.
SENS Stock Could Go Back Up, Still a Risky Bet for Investors
SENS stock is down sharply from its peaks. Will Senseonics stock go back up? Should you buy the stock before the FDA approval in 2021?
Best Healthcare Stocks for Investors to Buy Now, Defensive Bet
Healthcare stocks can be a good defensive bet in current times. What are the best healthcare stocks that you can buy in 2021?
Will Clover Health (CLOV) Stock Go Up and Should You Buy It Now?
Clover Health (CLOV) stock has pulled back sharply from its peak. Investors want to know if now is a good time to buy the stock.
Sema4 Holdings (SMFR) Stock Is a Good Buy After the CMLF Merger
Sema4 Holdings (SMFR) and CMLF completed their merger on July 22. What's SMFR's stock forecast after the merger?
Moderna Stock (MRNA) Could Keep Delivering Value for Years
Moderna stock has tripled this year. After its price surge, investors want to know Moderna's (MRNA) stock forecast for 2025. Does it look promising?
23andMe’s Stock Price Prediction: Will ME Recover After Dropping?
23andMe (ME) stock has fallen 45 percent from its peaks. Many investors wonder if the biotech stock will go back up. Here's what we know.
Erasca (ERAS) Stock Has Potential, Good Bet for High-Risk Investors
Erasca is listing on July 16. Is the stock a good buy for investors? What’s the forecast for the clinical-stage company?
Why Clover Health Stock Is an Attractive Buy After the Crash
Clover Health stock is down almost 70 percent from its 52-week highs. Why is CLOV stock going down and will it go back up?
Walmart Launches Cheaper Insulin Pen, Stock Gets a Boost
Walmart has dropped an insulin pen that's cheaper than high-price alternatives. Is Walmart's insulin pen safe? What can consumers expect?
Cathie Wood Is Bullish on Gene Editing Stocks: Should You Also Be?
Gene-editing stocks are rising in popularity, and Cathie Wood is also backing them. What should investors know about gene-editing stocks?
Grail Isn't Publicly Traded Yet Despite Groundbreaking Cancer Test
Grail is a biotechnology startup focused on its early blood test to screen for over 50 types of cancer. Scientists say it's accurate enough for use to detect cancer earlier.
CLOV Stock Forecast: Can Reddit Traders Take It to the Moon Again?
Reddit traders are targeting yet another short squeeze in Clover Health stock. What's the forecast for CLOV stock and can it go to the "moon" again?
Doximity IPO Stock Is a Buy Based on Its Fundamentals and Outlook
Doximity, a social network for physicians, is scheduled to go public soon. Unlike most of the recent companies that have gone public, Doximity is profitable. Should you buy Doximity IPO stock?
Buy 23andMe (ME) Stock Now Before WallStreetBets Ninjas Notice
23andMe stock has fallen sharply from its peaks. What’s the forecast for ME, and is it the next short squeeze target for Reddit investors?
Could 23andMe (ME) Stock Rise Even Further?
23andMe (ME) stock had a strong stock market debut through its SPAC merger with VGAC. How high can ME stock go?
Atai Life Sciences Is Going Public, Stock Looks Like a Good Buy
Atai Life Sciences is going public this week. What’s the forecast for Atal Life Sciences stock and should you buy the IPO?
Novavax Vaccine Is Spearheaded by Institutional Investors
As the Novavax COVID-19 vaccine enters the U.S. market, the people behind the company are coming into question. Who owns Novavax?